NL8103842A - Vaccin tegen pertussis. - Google Patents

Vaccin tegen pertussis. Download PDF

Info

Publication number
NL8103842A
NL8103842A NL8103842A NL8103842A NL8103842A NL 8103842 A NL8103842 A NL 8103842A NL 8103842 A NL8103842 A NL 8103842A NL 8103842 A NL8103842 A NL 8103842A NL 8103842 A NL8103842 A NL 8103842A
Authority
NL
Netherlands
Prior art keywords
vaccine
pertussis
bacteria
bordetella
live
Prior art date
Application number
NL8103842A
Other languages
English (en)
Dutch (nl)
Original Assignee
Dso Pharmachim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to DE19803043291 priority Critical patent/DE3043291A1/de
Priority to US06/207,434 priority patent/US4338299A/en
Priority to GB8102101A priority patent/GB2091551B/en
Priority to BE0/205617A priority patent/BE889899A/fr
Application filed by Dso Pharmachim filed Critical Dso Pharmachim
Priority to NL8103842A priority patent/NL8103842A/nl
Publication of NL8103842A publication Critical patent/NL8103842A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NL8103842A 1980-11-17 1981-08-17 Vaccin tegen pertussis. NL8103842A (nl)

Priority Applications (5)

Application Number Priority Date Filing Date Title
DE19803043291 DE3043291A1 (de) 1980-11-17 1980-11-17 Vakzine gegen keuchhusten
US06/207,434 US4338299A (en) 1980-11-17 1980-11-17 Vaccine against pertussis
GB8102101A GB2091551B (en) 1980-11-17 1981-01-23 Vaccine against pertussis
BE0/205617A BE889899A (fr) 1980-11-17 1981-08-07 Vaccin contre la coqueluche
NL8103842A NL8103842A (nl) 1980-11-17 1981-08-17 Vaccin tegen pertussis.

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
DE19803043291 DE3043291A1 (de) 1980-11-17 1980-11-17 Vakzine gegen keuchhusten
DE3043291 1980-11-17
US20743480 1980-11-17
US06/207,434 US4338299A (en) 1980-11-17 1980-11-17 Vaccine against pertussis
GB8102101A GB2091551B (en) 1980-11-17 1981-01-23 Vaccine against pertussis
GB8102101 1981-01-23
BE205617 1981-08-07
BE0/205617A BE889899A (fr) 1980-11-17 1981-08-07 Vaccin contre la coqueluche
NL8103842A NL8103842A (nl) 1980-11-17 1981-08-17 Vaccin tegen pertussis.
NL8103842 1981-08-17

Publications (1)

Publication Number Publication Date
NL8103842A true NL8103842A (nl) 1983-03-16

Family

ID=37733814

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8103842A NL8103842A (nl) 1980-11-17 1981-08-17 Vaccin tegen pertussis.

Country Status (5)

Country Link
US (1) US4338299A (de)
BE (1) BE889899A (de)
DE (1) DE3043291A1 (de)
GB (1) GB2091551B (de)
NL (1) NL8103842A (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5000952A (en) * 1988-08-02 1991-03-19 The Board Of Trustees Of The Leland Stanford, Jr. University Polypeptide pertussis toxin vaccine
IT1236971B (it) * 1989-11-03 1993-05-07 Eniricerche Spa Regione promotore dei geni codificanti le subunita' piliniche fim2, fm3 e fimx di bordetella pertussis e loro impiego per l'espressione di geni che codificano una proteina di interesse.
EP0484621A3 (en) * 1990-07-11 1992-08-26 American Cyanamid Company Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertussis antigens

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US24748A (en) * 1859-07-12 Improvement in paint-cans
US2837460A (en) * 1952-10-23 1958-06-03 Lilly Co Eli Pertussis vaccine preparation
US3395219A (en) * 1964-12-11 1968-07-30 Merck & Co Inc Process for production of pertussis antigen
IL24946A (en) * 1965-01-19 1969-05-28 Merck & Co Inc Process for preparing antibodies in cilus pertussis
NL6600706A (de) * 1965-02-05 1966-08-08
US3465078A (en) * 1965-10-21 1969-09-02 Sydney Z Spiesel Method of recovering antigens from bordetella pertussis cells
US3577319A (en) * 1968-05-27 1971-05-04 American Cyanamid Co Large scale cultivation of bordetella pertussis cells for vaccine production
DE2461439C3 (de) * 1974-12-24 1980-03-20 Behringwerke Ag, 3550 Marburg Verfahren zur Herstellung eines schützenden Antigens von Bordetella Pertussis sowie jenes enthaltendes Mittel
DE2717475A1 (de) * 1977-04-20 1978-12-07 R & Z Vermoegensverw Gmbh Peptidkomplex mit resistenzsteigernder wirkung gegen eine infektion mit bordetella pertussis keimen, seine verwendung zu impfstoffzubereitungen und diagnostischen zwecken

Also Published As

Publication number Publication date
GB2091551B (en) 1984-10-24
BE889899A (fr) 1981-12-01
GB2091551A (en) 1982-08-04
US4338299A (en) 1982-07-06
DE3043291A1 (de) 1982-07-01

Similar Documents

Publication Publication Date Title
JP3107568B2 (ja) ブドウ膜炎の処置
Baer et al. Successful prophylaxis against rabies in mice and rhesus monkeys: the interferon system and vaccine
JPH06501479A (ja) 抗原担体
ATE271060T1 (de) Verbindungen und pharmazeutische zusammensetzungen zur behandlung und prophylaxe bakterieller infektionen
RU94002475A (ru) Фармацевтическая композиция и ее применение для лечения вирусных инфекций
US3888977A (en) Modified neurotoxin
KR100272743B1 (ko) Hiv 감염의 치료에 유용한 미코박테리움 바케로부터의 항원물질
EP0484438B1 (de) Biologisches präparat und seine verwendung
McKercher et al. Foot-and-mouth disease in swine: I. The immune response of swine to chemically-treated and non-treated foot-and-mouth disease virus
Polk The enhancement of host defenses against infection—Search for the Holy Grail?
NL8103842A (nl) Vaccin tegen pertussis.
Shepard Combinations involving dapsone, rifampin, clofazimine, and ethionamide in the treatment of M. leprae infections in mice
US6726913B1 (en) Treatment of dermal tumors, warts, and viral infections of the respiratory tract in humans using heat-killed P. acnes
Benjavongkulchai et al. An immunogenicity and efficacy study of purified chick embryo cell culture rabies vaccine manufactured in Japan
US4892876A (en) Method for inhibiting HIV and an pharmaceutical composition therefor
Korting et al. Ceftriaxone given repeatedly cures manifest syphilis in the rabbit
CA1171357A (en) Vaccine against pertussis
Rudra et al. A preliminary report on the treatment of lathyrism with parenteral methionine
RU2056861C1 (ru) Ассоциированная вакцина против сибирской язвы и ящура и способ профилактики сибирской язвы и ящура
Smith et al. Necrobacillosis and immunity in mice
JPH01139534A (ja) 人体免疫不全ウイルス感染における人体免疫のための薬剤
EP0299082B1 (de) Antivirales mittel
RU2245719C2 (ru) Тимолсодержащая композиция, полезная для лечения устойчивых к лекарственным средствам бактериальных инфекций
RU2521513C1 (ru) Применение этония в качестве адъюванта для производства сорбированной противоящурной вакцины
Nabi et al. Methylmercury and thimerosal

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BV The patent application has lapsed